Aldafermin |
| Katalog-Nr.GC72387 |
Aldafermin (NGM282) ist ein Analogon des Fibroblasten-Wachstumsfaktors 19. Aldafermin kann für die Erforschung der nichtalkoholischen Steatohepatitis (NASH) verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1616639-03-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Aldafermin can inhibit bile acid synthesis and regulates metabolic homeostasis[1].
References:
[1]. Stephen A Harrison, et al. Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis. Gastroenterology. 2021 Jan;160(1):219-231.e1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *